Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Apr 19, 2024 3:18pm
39 Views
Post# 35998686

RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an
QContinuum1 wrote: They don't need to buy more bolt-on pennies on the dollar outfits to start executing on their business plan.  Using the money they have now to do another M&A exercise is just kicking the can down the road and does nothing in the near term for shareholders.  And while it may not mean dilution (although I can see how some shares would be offered to managers etc), the current massive float hangs like an anvil and the spectre of a RS is always there.

LABS has all they need to grow the business in many different jurisdictions.  Another ego driven M&A exercise is not what is needed now.




lol ---whats EGO got to do with making a smart M&A -- i have a feeling you fealt that way when they bought VIVO.......
and as you can see that would have been the absolute worst position as they have now prooven what a excellent aquisition VIVO was, once they were fully absorbed.

any M&A would have to be done with results like VIVO merger in mind, management hit that nail 100% on the head,so to assume they would try to do a M&A that would not affect the company positivly dosent make sense! 
and my point was that insted of having to float shares with SP being where it is would be worse than using the cash on hand both for shareholders (no dilution) and for MPL as you have better negotiating position using cash.


if we are making money hand over fist and have to buy product (flower) to make our oild etc. and if it makes sense and is cheaper than purchasing raw materials why not look at aquiering a producer that may be in trouble so you dont have to go outside to buy flower. that way you are not relying on outside sources for raw materials, you can controll quality etc. all kinds of upside?!

just one example of where it may make sense ...not saying it does i have no idea as we are not privee to that info on what and how much flower is needed on a monthly supply basis ...waht i do know is that if they werent lying about whats happening and going to happen re:sales our needs for Flower are going up..way up...!
<< Previous
Bullboard Posts
Next >>